Southern Diagnostic Laboratories bought by Solstas

Birmingham, AL-based Southern Diagnostic Laboratories is being acquired by one of the larger U.S. medical testing companies, Solstas Lab Partners. Solstas CEO David Weavil said this and several other recent acquisitions will allow Solstas to offer "local, community-based" services.

Both companies handle blood and pathology testing, among other types of lab work.

The North Carolina-based company recently acquired Nextwave Diagnostic Laboratories and Wilmington Pathology Laboratory. And it's been on a shopping spree for companies since venture capital fund Ascension Health Ventures invested an undisclosed sum in it in June.

The terms of the Southern Diagnostic deal were not disclosed.

- get more from

Suggested Articles

The immunoassay will measure neurofilament light chain protein levels, found in the blood and cerebrospinal fluid, and linked to nerve damage.

Emmecell aims to make corneal transplant surgery, which can take up to a year to heal from and fails up to 20% of the time, a relic of the past.

Seven developers will provide digital health solutions aimed at the COVID-19 pandemic, including smartphone apps, wearables and big data programs.